Literature DB >> 8636415

The relationship between the fibrinogen D domain self-association/cross-linking site (gammaXL) and the fibrinogen Dusart abnormality (Aalpha R554C-albumin): clues to thrombophilia in the "Dusart syndrome".

M W Mosesson1, K R Siebenlist, J f Hainfeld, J S Wall, J Soria, C Soria, J P Caen.   

Abstract

Cross-linking of fibrinogen at its COOH-terminal gamma chain cross-linking site occurs in the presence of factor XIIIa due to self-association at a constitutive D domain site ("gammaXL"). We investigated the contribution of COOH-terminal regions of fibrinogen Aalpha chains to the gammaXL site by comparing the gamma chain cross-linking rate of intact fibrinogen (fraction I-2) with that of plasma fraction I-9, plasmic fraction I-9D, and plasmic fragment D1, which lack COOH-terminal Aalpha chain regions comprising approximately 100, approximately 390, and 413 residues, respectively. The cross-linking rates were I-2 > I-9 > 1-9D = D1, and indicated that the terminal 100 or more Aalpha chain residues enhance gammaXL site association. Fibrinogen Dusart, whose structural abnormality is in the COOH-terminal "alphaC" region of its Aalpha chain (Aalpha R554C-albumin), is associated with thrombophilia ("Dusart Syndrome"), and is characterized functionally by defective fibrin polymerization and clot structure, and reduced plasminogen binding and tPA-induced fibrinolysis. In the presence of XIIIa, the Dusart fibrinogen gamma chain cross-linking rate was about twice that of normal, but was normalized in proteolytic fibrinogen derivatives lacking the Aalpha chain abnormality, as was reduced plasminogen binding. Electron microscopy showed that albumin-bound Dusart fibrinogen "alphaC" regions were located in the vicinity of D domains, rather than at their expected tethered location near the fibrinogen E domain. In addition, there was considerable fibrinogen aggregation that was attributable to increased intermolecular COOH-terminal Aalpha chain associations promoted by untethered Dusart fibrinogen aC domains. We conclude that enhanced Dusart fibrinogen self-assembly is mediated through its abnormal alphaC domains, leads to increased gammaXL self-association and gamma chain cross-linking potential, and contributes to the thrombophilia that characterizes the "Dusart Syndrome."

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8636415      PMCID: PMC507315          DOI: 10.1172/JCI118677

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  38 in total

1.  The effect of fibrin structure on fibrinolysis.

Authors:  D A Gabriel; K Muga; E M Boothroyd
Journal:  J Biol Chem       Date:  1992-12-05       Impact factor: 5.157

2.  Amino acid sequence studies on the alpha chain of human fibrinogen. Covalent structure of the alpha-chain portion of fragment D.

Authors:  R F Doolittle; K G Cassman; B A Cottrell; S J Friezner; T Takagi
Journal:  Biochemistry       Date:  1977-04-19       Impact factor: 3.162

3.  Plasminogen and plasmin.

Authors:  K C Robbins; L Summaria
Journal:  Methods Enzymol       Date:  1976       Impact factor: 1.600

4.  Location of the binding site "b" for lateral polymerization of fibrin.

Authors:  N Hasegawa; S Sasaki
Journal:  Thromb Res       Date:  1990-01-15       Impact factor: 3.944

5.  Characterization of the gamma chain platelet binding site on fibrinogen fragment D.

Authors:  N E Kirschbaum; M W Mosesson; D L Amrani
Journal:  Blood       Date:  1992-05-15       Impact factor: 22.113

6.  Human fibrinogen heterogeneities. I. Structural and related studies of plasma fibrinogens which are high solubility catabolic intermediates.

Authors:  M W Mosesson; J S Finlayson; R A Umfleet; D Galanakis
Journal:  J Biol Chem       Date:  1972-08-25       Impact factor: 5.157

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  The preparation and properties of human fibrinogen of relatively high solubility.

Authors:  M W Mosesson; S Sherry
Journal:  Biochemistry       Date:  1966-09       Impact factor: 3.162

9.  A correlation between thrombotic disease and a specific fibrinogen abnormality (A alpha 554 Arg-->Cys) in two unrelated kindred, Dusart and Chapel Hill III.

Authors:  Y Wada; S T Lord
Journal:  Blood       Date:  1994-12-01       Impact factor: 22.113

10.  A new type of congenital dysfibrinogenaemia with defective fibrin lysis--Dusard syndrome: possible relation to thrombosis.

Authors:  J Soria; C Soria; P Caen
Journal:  Br J Haematol       Date:  1983-04       Impact factor: 6.998

View more
  7 in total

1.  Ligneous conjunctivitis: biochemical evidence for hypofibrinolysis.

Authors:  M L Ramsby; P C Donshik; G S Makowski
Journal:  Inflammation       Date:  2000-02       Impact factor: 4.092

2.  VLITL is a major cross-β-sheet signal for fibrinogen Aα-chain frameshift variants.

Authors:  Cyrille Garnier; Fatma Briki; Brigitte Nedelec; Patrick Le Pogamp; Ahmet Dogan; Nathalie Rioux-Leclercq; Renan Goude; Caroline Beugnet; Laurent Martin; Marc Delpech; Frank Bridoux; Gilles Grateau; Jean Doucet; Philippe Derreumaux; Sophie Valleix
Journal:  Blood       Date:  2017-10-31       Impact factor: 22.113

Review 3.  Structure and function of human fibrinogen inferred from dysfibrinogens.

Authors:  Michio Matsuda; Teruko Sugo
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

Review 4.  Fibrinogen αC domain: Its importance in physiopathology.

Authors:  Jeannette Soria; Shahsoltan Mirshahi; Sam Qiumars Mirshahi; Remi Varin; Linda L Pritchard; Claudine Soria; Massoud Mirshahi
Journal:  Res Pract Thromb Haemost       Date:  2019-02-15

5.  Erythrocyte Fraction in Thrombi Is Increased with Serum Iron by Influencing Fibrin Networks via Oxidative Stress.

Authors:  Mingli Liu; Minghui Chen; Zhongfei Hao; Qingbin Li; Yan Feng; Yongli Li; Ruiyan Li
Journal:  Oxid Med Cell Longev       Date:  2021-12-24       Impact factor: 6.543

6.  Development of a mesoscopic framework spanning nanoscale protofibril dynamics to macro-scale fibrin clot formation.

Authors:  Naoki Takeishi; Taiki Shigematsu; Ryogo Enosaki; Shunichi Ishida; Satoshi Ii; Shigeo Wada
Journal:  J R Soc Interface       Date:  2021-11-10       Impact factor: 4.118

7.  MetAmyl: a METa-predictor for AMYLoid proteins.

Authors:  Mathieu Emily; Anthony Talvas; Christian Delamarche
Journal:  PLoS One       Date:  2013-11-19       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.